{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-074243","form_type":"8-K","ticker":"DSGN","cik":"0001807120","company_name":"Design Therapeutics, Inc.","filed_at":"2024-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.228749+00:00","generated_at":"2026-06-01T04:09:13.690658+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Design Therapeutics stockholders elect Pratik Shah as Class III director, ratify EY auditor","bullets":["Pratik Shah, Ph.D. elected as Class III director with ~42.8M votes for, ~3.5M withheld (7.7M broker non-votes).","Ernst & Young LLP ratified as independent auditor for FY2024 (53,981,806 for, 2,764 against, 2 abstentions).","Annual Meeting held June 13, 2024; 56,495,039 shares outstanding and entitled to vote as of record date."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-074243","json":"https://secwatch.observer/filing/0000950170-24-074243.json","markdown":"https://secwatch.observer/filing/0000950170-24-074243.md","text":"https://secwatch.observer/filing/0000950170-24-074243.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1807120/000095017024074243/0000950170-24-074243-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1807120/000095017024074243/dsgn-20240613.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:09:13.690658+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}